Breda M - Search Results

1

Determination of exemestane, a new aromatase inhibitor, in plasma by high-performance liquid chromatography with ultraviolet detection.

Breda M, Pianezzola E, Benedetti MS. Breda M, et al. J Chromatogr. 1993 Oct 29;620(2):225-31. doi: 10.1016/0378-4347(93)80008-r. J Chromatogr. 1993. PMID: 8300790

2

Determination of 3'-deamino-3'-[2(S)-methoxy-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detection.

Breda M, Pianezzola E, Benedetti MS. Breda M, et al. J Chromatogr. 1992 Jul 24;578(2):309-15. doi: 10.1016/0378-4347(92)80431-o. J Chromatogr. 1992. PMID: 1400812

3

Determination of ethambutol in human plasma and urine by high-performance liquid chromatography with fluorescence detection.

Breda M, Marrari P, Pianezzola E, Strolin Benedetti M. Breda M, et al. J Chromatogr A. 1996 Apr 5;729(1-2):301-7. doi: 10.1016/0021-9673(95)01093-9. J Chromatogr A. 1996. PMID: 9004954 Clinical Trial.

4

A study of the effects of rifabutin on isoniazid pharmacokinetics and metabolism in healthy volunteers.

Breda M, Pianezzola E, Strolin Benedetti M, Efthymiopoulos C, Carpentieri M, Sassella D, Rimoldi R. Breda M, et al. Drug Metabol Drug Interact. 1992;10(4):323-40. doi: 10.1515/dmdi.1992.10.4.323. Drug Metabol Drug Interact. 1992. PMID: 1338982

5

Determination of PNU 157706, a new dual inhibitor of 5alpha-reductase, in rat plasma by high-performance liquid chromatography with ultraviolet detection.

Basileo G, Breda M, James CA. Basileo G, et al. Among authors: breda m. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):191-7. doi: 10.1016/s0378-4347(98)00412-5. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9869379

6

Effect of rifabutin on ethambutol pharmacokinetics in healthy volunteers.

Breda M, Benedetti MS, Bani M, Pellizzoni C, Poggesi I, Brianceschi G, Rocchetti M, Dolfi L, Sassella D, Rimoldi R. Breda M, et al. Pharmacol Res. 1999 Oct;40(4):351-6. doi: 10.1006/phrs.1999.0526. Pharmacol Res. 1999. PMID: 10527648 Clinical Trial.

7

Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.

Breda M, Benedetti MS, Battaglia R, Castelli MG, Poggesi I, Spinelli R, Hackett AM, Dostert P. Breda M, et al. Pharmacol Res. 2000 Feb;41(2):239-48. doi: 10.1006/phrs.1999.0584. Pharmacol Res. 2000. PMID: 10623492

8

Determination of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyldaunorubicin+ ++ and its 13-hydroxy metabolite by direct injection of human plasma into a column-switching liquid chromatography system with mass spectrometric detection.

Breda M, Basileo G, Fonte G, Long J, James CA. Breda M, et al. J Chromatogr A. 1999 Aug 27;854(1-2):81-92. doi: 10.1016/s0021-9673(99)00748-7. J Chromatogr A. 1999. PMID: 10497930

9

Simultaneous determination of estramustine phosphate and its four metabolites in human plasma by liquid chromatography-ionspray mass spectrometry.

Breda M, Basileo G, James CA. Breda M, et al. Biomed Chromatogr. 2004 Jun;18(5):293-301. doi: 10.1002/bmc.319. Biomed Chromatogr. 2004. PMID: 15236437

10

Simultaneous determination of JTT-501 and its main metabolite in human plasma by liquid chromatography-ionspray mass spectrometry.

Breda M, Basileo G, James CA. Breda M, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 25;794(1):167-74. doi: 10.1016/s1570-0232(03)00453-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12888209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters